Drugmakers Condemn Plan For COVID Vaccine Patent Waiver
(Reuters) – Global drugmakers condemned on Wednesday an initiative by four World Trade Organization members to introduce an intellectual property waiver for COVID-19 vaccines, saying it could undermine the industry’s ability to respond to health crises in future. The United States, the European Union, India and South Africa reached consensus on Tuesday on key elements…
